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ABSTRACT 
Purpose: This study was carried out to assess the radiation dose to patients undergoing interventional radiology 
procedures at Ramathibodi Hospital, Bangkok, Thailand. 
Methods: Data were collected from 60 patients under transarterial oily-chemoembolisation (TOCE) and femoral 
angiography performed with the Toshiba Infinix model VC-i FPD single plane system. Data were also collected from 60 
patients who underwent brain arteriovenous malformations (AVM) and dural-arteriovenous fistula (DAVF) embolisation, 
performed with the Toshiba Infinix model VF-i bi-plane systems. A built-in air kerma area product (KAP) meter 
calibrated in situ was used for the skin dose calculation. 
Results: The calibration coefficient of air kerma area product meter at tube voltage between 50 kV and 100 kV was 
found to vary within ± 5.07%, ± 7.2%, ± 4.86% from calibration coefficient of 80 kV for a single-plane, tube 1 and tube 
2 of bi-plane x-ray system, respectively. Mean air kerma area product values were 90.99  ±  52.89, 31.02  ±  17.92, 
33.11 ± 23.99  (Frontal),  35.01 ± 19.10  (Lateral),  50.15 ± 44.76  (Frontal),  97.31 ± 44.12  (Lateral)  Gy-cm
2 for 
transarterial oily-chemoembolisation, femoral angiography, diagnostic cerebral angiography, therapeutic cerebral 
angiography, respectively. The therapeutic cerebral angiography procedure was found to give the highest entrance dose, 
number of images and fluoroscopy time: 362.63 cGy (Lateral), 1015 images (Lateral) and 126 minutes, respectively. 
However, the highest air kerma area product value was from transarterial oily-chemoembolisation with 264.37 Gy-cm
2. 
There were 2 cases of therapeutic cerebral angiography, where the patient entrance dose was higher than 3 Gy in the 
frontal view, which reached the deterministic threshold for temporary epilation. 
Conclusion: Very wide variations were found in patient dose from different interventional procedures. There is a 
need for a dose record system to provide feedback to radiologists who perform the procedures; especially in cases where 
the dose exceeds the deterministic threshold. © 2011 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
In 2006, the National Council on Radiation 
Protection and Measurements (NCRP) published a report 
titled [1] ‘Ionizing Radiation Exposure of the Population 
of the United States’. The report showed that human-
made radiation contributes 50% of the radiation in our 
environment. Of this human-made radiation, 36% comes 
from diagnostic radiation, including 5% from general X-
rays and fluoroscopy, 24% from computed tomography 
(CT), and 7% from interventional radiology. It is clear 
that the biggest amount of radiation received by the 
population comes from general diagnostic radiation. 
Nonetheless, interventional radiology, though 
contributing a lesser extent of radiation delivery to the 
population, can emit very high individual doses that can 
possibly reach the deterministic threshold. 
Currently, interventional radiology procedures are 
increasingly performed in a number of pathological 
conditions. However, the high radiation dose from 
lengthy procedures can harm patients. Physicians are 
concerned about serious radiation-induced injury caused 
by high radiation skin dose or lengthy exposure to 
fluoroscopy in some procedures. In light of such 
concerns, the World Health Organization (WHO) and the 
German Institute for Radiation Hygiene (ISH) [2] 
organised a workshop on ensuring efficacy and radiation 
safety in interventional radiology. The Food and Drug 
Administration (FDA) published documents [3] on 
avoiding deterministic effects in cardiology procedures. 
The absorbed dose in the patient’s skin of 2 Gray (Gy) 
should raise concerns about the onset of transient 
erythema and 3  Gy for temporary epilation. [3] 
Information about the absorbed dose to skin should be 
included in the patient’s records.  
A number of investigators have utilised the air 
kerma area product values to assess radiation risk from 
fluoroscopic studies [4–9]. The air kerma area product is 
a better indicator of risk, compared to the entrance skin 
dose, due to the fact that air kerma area product is a 
product of entrance skin dose and field size [10]. This 
study was carried out to assess the radiation dose to 
patients undergoing interventional radiology procedures 
at Ramathibodi Hospital, Bangkok, Thailand. 
MATERIALS AND METHODS 
X-ray system 
The evaluation of patient dose was carried out at the 
radiology department of Ramathibodi Hospital. The 
interventional procedures were performed using two 
radiographic systems. The transarterial oily-
chemoembolisation and femoral angiography procedures 
were performed using the Toshiba Infinix VC-I FPD 
with X-ray generator model XTP 8100G (single-plane x-
ray system), whereas diagnostic cerebral angiography 
and therapeutic cerebral angiography (brain 
arteriovenous malformations and duralarteriovenous 
fistula embolization) were performed using Toshiba 
Infinix VB-I with X-ray generator model XTP 8100G 
(bi-plane x-ray system). The exposure parameters, such 
as tube potential and tube current, were controlled by 
automatic brightness control (ABC). The radiographic 
systems utilised 4 field diameters including 6  inches, 
8 inches, 12 inches, and 16 inches for Infinix VC-I FPD; 
and 5 inches, 7 inches, 9 inches and 12 inches for Infinix 
VB-I. All X-ray tubes were equipped with built-in air 
kerma area product meter (Diamentor K1S) at the 
collimator exit with capability to display the cumulative 
air kerma area product for fluoroscopic and radiographic 
examinations. The half-value-layer (HLV), tested at tube 
potential of 80 kVp and 74 kVp prior to the air kerma 
area product calibration, were 4.0 mmAl and 3.7 mmAl 
for Infinix VC-I FPD and Infinix VB-I, respectively. 
Air Kerma Area Product meter calibration 
Built-in air kerma area product meter was calibrated 
in situ with a calibrated ionisation chamber (Accu-Pro
TM). 
In this calibration procedure, a Fuji image photo-
stimulable phosphor plate was exposed and read by a 
Fuji FCR 5000 pulse for beam area determination. The 
calibration procedures and beam area determination were 
recommended by the International Atomic Energy 
Agency (IAEA TRS 457) [10]. The calibration 
coefficient of air kerma area product meter (NKAP) at 
tube voltage between 50 kV and 100 kV was found to 
vary within ± 5.07%, ± 7.20%, ± 4.86% from calibration 
coefficient of 80 kV for Infinix VC-I FPD, Infinix VB-I 
tube 1 and tube 2 respectively. 
Patient data collection 
A total of 120 patients (78 male, 42 female, mean 
age of 51.29 ± 16.88 and 53.43 ± 20.94 years for male 
and female, respectively) who underwent interventional 
radiology procedures participated in this study and 
signed a consent form. Ethical clearance was obtained 
from the Ramathibodi Hospital research ethics 
committee. Patient-specific data, i.e., couch position, 
field of view (FOV), kerma area product, and tube 
potential were collected from the displayed monitor for 
purpose of dose calculation. 
Air kerma area product was corrected with 
calibration coefficient of air kerma area product meter 
for average tube potential of each projection. Entrance 
skin dose (ESD) was calculated from air kerma area 
product ( ), beam area (Anam) and calibration 
coefficient of air kerma area product meter ( ) at 
calibrated distance (see equation of entrance dose below) 
to focal-to-skin distance (FSD) by inverse square law 
and multiplied by backscatter factor for each series. 
Backscatter factor was interpolated from the tabulated 
data by using half value layer, and the focal-to-skin 
distance was calculated from the couch position. 
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Table 1 The mean, the median and the standard deviation values of the kVp, mA, ms, Field of View (FOV). 
kVp  mA  ms  FOV 
 
mean  median  SD  mean  median  SD  mean  median  SD  mean  median  SD 
TOCE 82.9  82  5.03  124.2  125  25.67  69.1  74.9  18.43  13.4  12  2.59 
Femoral 
angiography   80.3  80  1.91  79.9 80 43.55  21.8 10  21.99  15.9 16  0.49 
Diagnostic cerebral 
angiography                      
   Frontal  76  74  3.75  259.3  160  156.44  54.7  63  23.32  9  9  1.21 
   Lateral  74  74  0.00  399.4  400  7.18  41.3  40  10.65  10  9  1.59 
Therapeutic cerebral 
angiography                     
   Frontal  75.6  74  2.57  217.3  160  110.48  63.6  66  16.44  7.7  9  2.06 
   Lateral  74.6  74  2.38  380.8  400  70.55  46.3  43  18.23  8.7  9  2.58 
 
Table 2 The mean, the median and the standard deviation values of air kerma-area product (KAP), Entrance dose (ED), Number of images and 
Fluoroscopy time. 
KAP (cGy-cm
2)  ED (mGy)  Number of images  Fluoroscopy time (min) 
  No. 
mean  median  SD  mean  median SD  mean  median  SD  mean  median  SD 
TOCE 30  9099.41  7719.30  5288.79 394.86  339.55  292.28 104.83  97.5  45.71  14.94  8.8  12.87 
Femoral angiography   30  3101.87  2355.93  1791.89 100.36  78.21  59.65  220.73  195.5  71.00  5.9  4.95  4.11 
Diagnostic cerebral 
angiography                           
   Frontal  30  3310.97  2724.04  2398.89 400.40  308.65  318.48 378.23  284.5  287.26 
   Lateral    3500.68  3328.83  1909.86 154.77  125.96  93.56  118.13  110.5  37.24 
13.27 12.25  7.25 
Therapeutic cerebral 
angiography                          
   Frontal  30  5014.75  3706.52  4476.37 876.52  718.48  773.43 354.06  295.5  224.42 
   Lateral    9731.47  9404.30  4411.78 591.93  606.57  312.42 334.73  317.5  177.97 
40.1 32.8 27.84 
*n = 33, percentages in parentheses. 
RESULTS AND DISCUSSION 
Table  1 shows the mean, median and standard 
deviation values of the kVp, mA, ms, and field of view 
(FOV). The mean values of tube potential for 
transarterial oily-chemoembolisation, femoral 
angiography, diagnostic cerebral angiography, 
therapeutic cerebral angiography are 82.9, 80.3, 76 
(frontal), 74 (lateral), 75.6 (frontal) and 74.6 (lateral) 
kVp, respectively. The mean, median,  maximum and 
standard deviation values of air kerma area product 
(KAP), entrance skin dose (ESD), number of images and 
fluoroscopy time are shown in Table 2 and 3. 
In this study, the highest entrance dose, number of 
images and fluoroscopy time of 362.63  cGy, 1015 
images and 126 minutes, respectively, were found in the 
lateral tube position of therapeutic cerebral angiography. 
However, the highest air kerma area product was from 
transarterial oily-chemoembolisation with a value of 
264.37 Gy-cm
2. There were two patients who received 
entrance doses higher than 3  Gy in a frontal view of 
therapeutic cerebral angiography. This dose level is 
higher than a threshold dose for temporary epilation. 
From the results, wide variations (9.89–230.00 Gy-
cm
2 and 15.47–362.63  cGy in therapeutic cerebral 
angiography) were found in air kerma area product and 
entrance skin dose. Complicated procedures require more 
operating time and deliver higher radiation doses to 
patients, compared to common and non-complicated 
procedures. Differences in the irradiated field size can 
also cause the difference in radiation dose to patients. In 
this study, it was found that larger irradiated fields such 
as transarterial oily-chemoembolisation produced higher 
air kerma area product than the smaller field in 
therapeutic cerebral angiography. However, the entrance 
skin dose from transarterial oily-chemoembolisation was 
smaller, as it required less irradiation time. Table  4 
shows the comparison between air kerma area product 
and entrance skin dose from this study with other 
published data. The mean air kerma area product of this 
study was lower than other studies in transarterial oily-
chemoembolisation and femoral angiography except 
when compared with Veno’s study in transarterial oily-
chemoembolisation. In diagnostic and therapeutic 
cerebral angiography procedures, the mean air kerma 
area product was lower than in other studies, when Urairat et al. Biomed Imaging Interv J 2011; 7(3):e22   4 
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Table 3 Mean Fluoroscopy, KAP and ED of this study and other study. 
 
Procedure    Study  Mean Fluoroscopy 
time (min)  Mean KAP (Gy-cm
2)  Mean ED 
(mGy) 
TOCE   This  study  14.94  90.99  394.86 
    Wongsanon S., et al. [12]  8.58  121.09  370 
    Donald L., et al.[13]  16.8  282.32  1,406 
    Vano et al. [14]  -  81.7  500 
Femoral angiography     This study  5.9  31.02  100.36 
    Vano et al. [14]  -  66.6  - 
    Ioaninis A. Tsalafoutas, et al. [15]  2.6  68  257 
   McParland  [16]  7.2  46.7  - 
Frontal 33.11  400.40  Diagnostic cerebral 
angiography   Lateral 
This study  13.27 
35.01 154.77 
    Ioaninis A. Tsalafoutas, et al. [15]  4.3  50  349 
   McParland  [16]  12.1  74.1  220 
    Marshall, et al. [17]  -  48.5  150 
Frontal 50.15  876.52  Therapeutic cerebral 
angiography  Lateral 
This study  40.1 
97.31 591.93 
    Donald L., et al.[13]  92.5  339.76  3791 
   McParland  [16]  34.1  105  - 
   Marshall, et al. [17]  - 122  - 
 
compared with each tube. But it was higher than that of 
some studies when compared with both tubes. 
To utilise the displayed air kerma area product 
values from the console screen, with proper calibration 
values, conversion of air kerma area product to entrance 
skin dose can be carried out and used. In this study, to set 
up a concerned level for deterministic risk of 2  Gy, 
correlations (R
2) between the air kerma area product 
values and the calculated entrance skin dose of 0.83, 0.98, 
0.86, 0.77, 0.92, 0.69 for transarterial oily-
chemoembolisation, femoral angiography, diagnostic 
cerebral angiography frontal and lateral, therapeutic 
cerebral angiography frontal and lateral, respectively, 
were found. The corresponding air kerma area product 
values were 410.77, 606.66, 162.73, 464.11, 118.12 and 
335.21 Gy-cm
2. 
CONCLUSION 
High-dose radiological procedures such as 
interventional radiology have been known to expose 
patients to high doses of radiation. The high dose levels 
can sometimes reach the deterministic risk threshold. Air 
kerma area product meters are now commonly 
incorporated with the fluoroscopic unit to provide 
feedback on radiation dose emitted from the x-rays tube. 
The air kerma area product meter calibrated using proper 
in situ protocol can be used as a monitoring tool to alert 
clinicians regarding deterministic risk of radiation such 
as early transient erythema or epilation.  
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